Biomarin Pharmaceutical Inc (BMRN)
82.44
-1.36
(-1.62%)
USD |
NASDAQ |
May 03, 16:00
82.46
+0.02
(+0.03%)
After-Hours: 20:00
Biomarin Pharmaceutical Price: 82.44 for May 3, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 03, 2024 | 84.80 | 84.80 | 82.32 | 82.44 | 1.633M |
| May 02, 2024 | 82.91 | 85.04 | 81.43 | 83.80 | 1.221M |
| May 01, 2024 | 81.07 | 83.98 | 80.50 | 83.33 | 1.882M |
| Apr 30, 2024 | 81.79 | 81.79 | 80.52 | 80.76 | 2.018M |
| Apr 29, 2024 | 81.65 | 83.85 | 81.44 | 82.13 | 2.009M |
| Apr 26, 2024 | 82.33 | 83.09 | 80.90 | 80.91 | 2.257M |
| Apr 25, 2024 | 86.26 | 86.78 | 81.00 | 82.17 | 7.884M |
| Apr 24, 2024 | 92.69 | 93.02 | 91.00 | 91.20 | 1.600M |
| Apr 23, 2024 | 90.03 | 92.22 | 89.93 | 92.06 | 1.299M |
| Apr 22, 2024 | 89.46 | 89.81 | 88.89 | 89.49 | 1.257M |
| Apr 19, 2024 | 89.67 | 90.18 | 88.29 | 88.63 | 1.779M |
| Apr 18, 2024 | 90.25 | 91.21 | 89.78 | 90.07 | 944850.0 |
| Apr 17, 2024 | 91.14 | 91.52 | 90.02 | 90.47 | 1.282M |
| Apr 16, 2024 | 90.93 | 91.78 | 90.16 | 90.87 | 1.236M |
| Apr 15, 2024 | 92.58 | 93.36 | 90.96 | 91.51 | 1.942M |
| Apr 12, 2024 | 91.26 | 93.26 | 91.09 | 92.22 | 2.420M |
| Apr 11, 2024 | 90.99 | 91.59 | 89.33 | 91.46 | 2.297M |
| Apr 10, 2024 | 88.38 | 90.41 | 87.79 | 90.21 | 2.205M |
| Apr 09, 2024 | 87.35 | 89.19 | 87.35 | 88.98 | 1.178M |
| Apr 08, 2024 | 87.00 | 88.11 | 86.95 | 87.28 | 1.345M |
| Apr 05, 2024 | 86.46 | 87.23 | 86.01 | 86.95 | 828855.0 |
| Apr 04, 2024 | 86.78 | 88.13 | 86.63 | 86.89 | 1.152M |
| Apr 03, 2024 | 86.48 | 87.72 | 86.48 | 86.78 | 1.166M |
| Apr 02, 2024 | 86.25 | 86.94 | 85.62 | 86.80 | 1.411M |
| Apr 01, 2024 | 86.98 | 87.30 | 86.09 | 87.10 | 715533.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
64.27
Minimum
Oct 02 2019
131.03
Maximum
Jul 20 2020
86.84
Average
85.23
Median
Jul 22 2022
Price Benchmarks
| Pfizer Inc | 27.81 |
| Eli Lilly and Co | 734.97 |
| Merck & Co Inc | 127.51 |
| Bristol-Myers Squibb Co | 43.99 |
| Moderna Inc | 125.00 |
Price Related Metrics
| PE Ratio | 77.05 |
| PS Ratio | 6.453 |
| PEG Ratio | 0.422 |
| Price to Book Value | 3.085 |
| Price to Free Cash Flow | 97.73 |
| Earnings Yield | 1.30% |
| Market Cap | 15.65B |
| PEGY Ratio | 0.422 |
| Operating PE Ratio | 90.02 |
| Normalized PE Ratio | 80.21 |